Cargando…
Infectivity and Drug Susceptibility Profiling of Different Leishmania-Host Cell Combinations
Protozoan parasites of the genus Leishmania are the causative agents of leishmaniasis, a spectrum of a disease that threatens public health worldwide. Although next-generation therapeutics are urgently needed, the early stage of the drug discovery process is hampered by very low hit rates from intra...
Autores principales: | Baek, Kyung-Hwa, Piel, Laura, Rosazza, Thibault, Prina, Eric, Späth, Gerald F., No, Joo Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281264/ https://www.ncbi.nlm.nih.gov/pubmed/32443883 http://dx.doi.org/10.3390/pathogens9050393 |
Ejemplares similares
-
Leishmania amazonensis Subverts the Transcription Factor Landscape in Dendritic Cells to Avoid Inflammasome Activation and Stall Maturation
por: Lecoeur, Hervé, et al.
Publicado: (2020) -
The enemy within: Targeting host–parasite interaction for antileishmanial drug discovery
por: Lamotte, Suzanne, et al.
Publicado: (2017) -
High Content Analysis of Primary Macrophages Hosting Proliferating Leishmania Amastigotes: Application to Anti-leishmanial Drug Discovery
por: Aulner, Nathalie, et al.
Publicado: (2013) -
Reverse Epidemiology: An Experimental Framework to Drive Leishmania Biomarker Discovery in situ by Functional Genetic Screening Using Relevant Animal Models
por: Piel, Laura, et al.
Publicado: (2018) -
Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening
por: Lamotte, S., et al.
Publicado: (2019)